IQV Long Call Strategy
IQV (IQVIA Holdings Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NYSE.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services.
IQV (IQVIA Holdings Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $28.77B, a trailing P/E of 20.96, a beta of 1.18 versus the broader market, a 52-week range of 134.65-247.05, average daily share volume of 1.8M, a public-listing history dating back to 2013, approximately 89K full-time employees. These structural characteristics shape how IQV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.18 places IQV roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long call on IQV?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current IQV snapshot
As of May 15, 2026, spot at $170.66, ATM IV 38.90%, IV rank 39.20%, expected move 11.15%. The long call on IQV below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on IQV specifically: IQV IV at 38.90% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 11.15% (roughly $19.03 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IQV expiries trade a higher absolute premium for lower per-day decay. Position sizing on IQV should anchor to the underlying notional of $170.66 per share and to the trader's directional view on IQV stock.
IQV long call setup
The IQV long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IQV near $170.66, the first option leg uses a $170.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IQV chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IQV shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $170.00 | $9.30 |
IQV long call risk and reward
- Net Premium / Debit
- -$930.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$930.00
- Breakeven(s)
- $179.30
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
IQV long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on IQV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$930.00 |
| $37.74 | -77.9% | -$930.00 |
| $75.48 | -55.8% | -$930.00 |
| $113.21 | -33.7% | -$930.00 |
| $150.94 | -11.6% | -$930.00 |
| $188.67 | +10.6% | +$937.38 |
| $226.41 | +32.7% | +$4,710.66 |
| $264.14 | +54.8% | +$8,483.93 |
| $301.87 | +76.9% | +$12,257.21 |
| $339.60 | +99.0% | +$16,030.49 |
When traders use long call on IQV
Long calls on IQV express a bullish thesis with defined risk; traders use them ahead of IQV catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
IQV thesis for this long call
The market-implied 1-standard-deviation range for IQV extends from approximately $151.63 on the downside to $189.69 on the upside. A IQV long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current IQV IV rank near 39.20% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on IQV should anchor more to the directional view and the expected-move geometry. As a Healthcare name, IQV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IQV-specific events.
IQV long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IQV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IQV alongside the broader basket even when IQV-specific fundamentals are unchanged. Long-premium structures like a long call on IQV are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current IQV chain quotes before placing a trade.
Frequently asked questions
- What is a long call on IQV?
- A long call on IQV is the long call strategy applied to IQV (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With IQV stock trading near $170.66, the strikes shown on this page are snapped to the nearest listed IQV chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IQV long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the IQV long call priced from the end-of-day chain at a 30-day expiry (ATM IV 38.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$930.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IQV long call?
- The breakeven for the IQV long call priced on this page is roughly $179.30 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IQV market-implied 1-standard-deviation expected move is approximately 11.15%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on IQV?
- Long calls on IQV express a bullish thesis with defined risk; traders use them ahead of IQV catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current IQV implied volatility affect this long call?
- IQV ATM IV is at 38.90% with IV rank near 39.20%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.